Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00347685 · ClinicalTrials.gov registry record · Phase 3
A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.
A Phase 3 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 650
- Enrollment target
NCT00347685 is a Phase 3 study that has completed, run by Bausch Health Americas. The registered enrollment target is 650 participants.
The verdict
NCT00347685, a Phase 3 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 650 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety of tramadol HCl ER following long-term treatment. The study hypothesis is that long-term treatment with tramadol HCl ER is safe and effective for the treatment of chronic, non-malignant pain.
Interventions
- DRUG tramadol ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2000-10 |
| Est. Completion | 2003-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00347685
The ClinicalTrials.gov registry entry for NCT00347685 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tramadol ER is the first listed.
NCT00347685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00347685 about?
NCT00347685 is a clinical study titled "A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.". The purpose of this study is to assess the safety of tramadol HCl ER following long-term treatment. The study hypothesis is that long-term treatment with tramadol HCl ER is safe and effective for the treatment of chronic, non-malignant pain.
What is the current status of trial NCT00347685?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 650 participants. The study started on 2000-10. Estimated completion is 2003-02.
What interventions are being tested in trial NCT00347685?
The interventions under investigation include: tramadol ER (DRUG).
Who is sponsoring clinical trial NCT00347685?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.